Is CVKD research on Rallies investment advice?

No. Rallies provides research, data, and educational context for CVKD. It does not provide personalized investment advice.

CVKD (Cadrenal Therapeutics, Inc. Common Stock) Stock Analysis - Financials

Cadrenal Therapeutics, Inc. Common Stock (CVKD) is a publicly traded Healthcare sector company. As of July 11, 2026, CVKD trades at $2.96 with a market cap of $9.27M and a P/E ratio of -0.44. CVKD moved -2.33% today. Year to date, CVKD is -57.37%; over the trailing twelve months it is -77.77%. Its 52-week range spans $2.55 to $22.90. Analyst consensus is buy with an average price target of $29.00. Rallies surfaces CVKD's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What are CVKD's key financials?

CVKD financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. CVKD recently traded at $2.96. Market cap is $9.27M. P/E ratio is -0.44. Revenue is $0.

CVKD Key Metrics

Key financial metrics for CVKD
Metric	Value
Price	$2.96
Market Cap	$9.27M
P/E Ratio	-0.44
EPS	$-6.64
Dividend Yield	0.00%
52-Week High	$22.90
52-Week Low	$2.55
Volume	39.91K
Avg Volume	0
Revenue (TTM)	$0
Net Income	$-13.24M
Gross Margin	0.00%

CVKD Analyst Consensus

2 analysts cover CVKD: 0 strong buy, 2 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $29.00.

Common questions about CVKD

What are CVKD's key financials?: CVKD financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. CVKD recently traded at $2.96. Market cap is $9.27M. P/E ratio is -0.44. Revenue is $0.
Is CVKD research on Rallies investment advice?: No. Rallies provides research, data, and educational context for CVKD. It does not provide personalized investment advice.